Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction
Journal of Ocular Pharmacology and Therapeutics · 01.11.2024 · 40 (9) · 562-570
DOI: 10.1089/jop.2024.0063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, online erschienen am 15.11.2024. Verfasst von Ashley Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Allergan, an AbbVie company, Irvine, California, USA. Hauptthemen laut MEDLINE: Meibomian Gland Dysfunction, Meibomian Glands, Severity of Illness Index. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Changes in meibum composition and quantity in meibomian gland dysfunction (MGD) result in tear film instability and dry eye. This exploratory study aimed to identify changes in (O-acyl)-ω-hydroxy fatty acid (OAHFA) and hydrocarbon chain (HC) unsaturation levels in meibum related to the presence and severity of MGD.
Methods
Meibum samples were collected from 3 cohorts of adults with no MGD, mild-to-moderate MGD, and severe MGD in a noninterventional clinical trial (NCT01979887). OAHFAs, cholesterol esters (CE), HC unsaturation, and HC length in the meibum samples were quantified with 1 H-nuclear magnetic resonance spectroscopy using 2 methods of normalization.
Results
Meibum samples from 62 subjects were analyzed: 21 non-MGD, 21 mild-to-moderate MGD, and 20 severe MGD. Meibum OAHFA and CE levels and HC unsaturation were reduced with increasing severity of MGD, with most pairwise comparisons significant ( P < 0.05, t -tests), following the order non-MGD > mild-to-moderate MGD > severe MGD. Regardless of the resonances used for normalization, each pairwise comparison of OAHFA, CE, and HC unsaturation levels in MGD (combined severities) versus non-MGD samples was significant ( P < 0.01, t -test). Analysis using various normalization equations showed reductions of 20%–22% for OAHFAs, 51%–57% for CE, and 36%–66% for HC unsaturation in MGD (combined severities) compared with non-MGD. HC length was not altered in MGD (combined severities) compared with non-MGD samples ( t -test).
Conclusions
Meibum OAHFA, CE, and HC unsaturation levels were reduced in MGD and were lowest in the severe MGD cohort. These findings may contribute to the understanding of the pathophysiology of MGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergan, an AbbVie company, Irvine, California, USA.
- Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, USA.
Förderung
- NEI NIH HHS
Zitieren
APA
Nguyen, A., Naidoo, K. K., Ajouz, L., Xu, X., Zhao, C., Robinson, M. R., & Borchman, D. (2024). Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction. Journal of Ocular Pharmacology and Therapeutics, 40(9), 562-570. https://doi.org/10.1089/jop.2024.0063
Vancouver
Nguyen A, Naidoo KK, Ajouz L, Xu X, Zhao C, Robinson MR, et al. Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction. Journal of Ocular Pharmacology and Therapeutics. 2024;40(9):562-570. doi:10.1089/jop.2024.0063
BibTeX
@article{Nguyen2024,
author = {Nguyen, Ashley and Naidoo, Kugen K and Ajouz, Layla and Xu, Xiaoming and Zhao, Cathy and Robinson, Michael R and Borchman, Douglas},
title = {Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
volume = {40},
number = {9},
pages = {562--570},
doi = {10.1089/jop.2024.0063}
}
EUVIMED